EHS/ Industrial Hygienist Entry Level at Clairo

Geneva, Illinois, United States

Apply Now

Not SpecifiedCompensation

Entry Level & New GradExperience Level

Full TimeJob Type

UnknownVisa

ManufacturingIndustries

Requirements

Bachelor's degree in Industrial Hygiene, Safety, Chemistry or related field
Minimum 3 years of experience in an industrial hygiene role, preferably in a manufacturing environment
Proficient knowledge of relevant laws, policies and procedures
Previous experience with OSHA, ACGIH, or other equivalent international organizations
Manufacturing experience
Preferred: Graduate degree in Industrial Hygiene or Certified Industrial Hygienist

Responsibilities

Implement an effective industrial hygiene program in accordance with Federal, State, Local, and Corporate requirements to monitor and assess employee exposure to health factors and measure program effectiveness
Partner with Health & Safety, Environmental, Nursing, HR, and Plant Leadership teams to identify and deploy solutions that reduce occupational exposures and improve industrial hygiene metrics
Develop strategies to reduce and eliminate health and wellness risks (e.g., air filtration, ventilation, engineering controls, PPE)
Conduct quarterly testing for ventilation, lead and air, noise levels, etc
Drive Clarios Best Business Practices and oversee its incorporation into the Clarios Management System
Educate and train plant hourly and salary personnel in industrial hygiene and ventilation practices and procedures
Lead efforts to manage Legal, Governmental, and Corporate industrial hygiene records according to standards
Review all manufacturing and support operations to assure ongoing, effective industrial hygiene practices
Assess and analyze data, summarize statistics, and compile reports for improvement initiatives
Maintain current awareness of applicable International, Federal, State, and local health, industrial hygiene, and safety regulations
Maintain professional competency through participation in professional education and training programs and completion of requirements to maintain credentials
Manage PPE room and locker assignments

Skills

Industrial Hygiene

EHS

Ventilation Testing

Air Monitoring

Noise Assessment

PPE

Engineering Controls

ACGIH Standards

Data Analysis

Training

Regulatory Compliance

Hazard Assessment

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free